Skipping sentinel lymph node biopsy and/or radiation therapy didn’t affect recurrence rates or survival for women age 70 and older diagnosed with early-stage, hormone-receptor-positive, HER2-negative, clinically node-negative breast cancer.
Reducing Treatment Seems Safe for Older Women With Early-Stage, Hormone-Receptor-Positive Breast Cancer
